ArticleAmerican journal of translational research2025
Impaired sleep efficiency predicts adverse prognosis in elderly pancreatic cancer patients: a retrospective case - control study based on wearable smart devices.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPancreatic cancer remains one of the most aggressive and lethal malignancies, with particularly poor prognoses in the elderly. Recent research has highlighted the role for lifestyle factors, including sleep, in cancer prognosis. This study aimed to evaluate the effect of sleep duration and quality, as measured by wearable smart devices, on the prognosis of pancreatic cancer in the elderly.
methodsThis retrospective case-control study included 200 elderly patients diagnosed with stage I pancreatic cancer who underwent first-line chemotherapy and Whipple surgery. Sleep metrics were recorded using the WHOOP Strap 2.0 device, and subjective sleep quality was assessed via the Richards-Campbell Sleep Questionnaire (RCSQ) and Pittsburgh Sleep Quality Index (PSQI). Patients were divided into good and poor prognosis groups based on postoperative complications.
resultsSignificant differences were observed in several sleep merasures between good and poor prognosis groups. The poor prognosis group exhibited longer wake after sleep onset (27.60 ± 4.14 minutes vs. 25.90 ± 3.28 minutes, P = 0.002) and reduced sleep efficiency (75 ± 0.20% vs. 74.5 ± 0.30%, P < 0.001). Additionally, time in bed was longer in the poor prognosis group (8.76 ± 0.21 hours vs. 8.60 ± 0.18 hours, P < 0.001). In correlational analysis, sleep efficiency significantly correlated with days of hospitalization (rho = 0.724, P < 0.001). Multivariate logistic regression identified days of hospitalization (OR 6.914, P = 0.018), time in bed (OR 5.489, P = 0.012), first time out of bed (OR 4.414, P = 0.041) and sleep efficiency (OR 26.595, P < 0.001) as independent predictors of prognosis.
conclusionSleep duration and quality are significantly associated with prognosis in elderly pancreatic cancer patients. Continuous sleep monitoring may inform individualized care strategies to improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.